Circulating tumor-associated antigen-specific IFNγ

PBMC immune checkpoint inhibition pancreatic cancer prognostic marker tumor-associated antigen-specific CD8 + T cells

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 31 12 2023
accepted: 22 02 2024
medline: 29 3 2024
pubmed: 29 3 2024
entrez: 29 3 2024
Statut: epublish

Résumé

CD8

Identifiants

DOI: 10.3389/fimmu.2024.1363568 PMID: 38550601 PMC: PMC10972947
pubmed: 38550601
doi: 10.3389/fimmu.2024.1363568
pmc: PMC10972947
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1363568

Informations de copyright

Copyright © 2024 Murakami, Takahama, Akita, Kobayashi, Masuta, Nagatsuka, Higashiguchi, Tomokuni, Yoshida, Takahashi, Doki, Eguchi, Matsuura and Yamamoto.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Hirotomo Murakami (H)

Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.

Shokichi Takahama (S)

Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.

Hirofumi Akita (H)

Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Next-Generation Precision Medicine Research Center, Osaka International Cancer Institute, Osaka, Japan.

Shogo Kobayashi (S)

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.

Yuji Masuta (Y)

Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.

Yuta Nagatsuka (Y)

Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.

Masaya Higashiguchi (M)

Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.

Akira Tomokuni (A)

Department of Gastroenterological Surgery, Osaka General Medical Center, Osaka, Japan.

Keiichi Yoshida (K)

Next-Generation Precision Medicine Research Center, Osaka International Cancer Institute, Osaka, Japan.

Hidenori Takahashi (H)

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.

Yuichiro Doki (Y)

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.

Hidetoshi Eguchi (H)

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.

Nariaki Matsuura (N)

Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.

Takuya Yamamoto (T)

Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
Next-Generation Precision Medicine Research Center, Osaka International Cancer Institute, Osaka, Japan.
Laboratory of Aging and Immune Regulation, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
Department of Virology and Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan.

Classifications MeSH